Liposomal NMN vs Regular NMN: What’s the Difference?
If you are comparing NMN supplements, one of the biggest differences you will encounter is the delivery format.
Some products contain conventional NMN powder inside a capsule. Others combine NMN with phospholipids and are marketed as liposomal NMN.
The idea behind liposomal delivery sounds straightforward: use lipid-based structures around or alongside an active ingredient with the aim of protecting it during digestion and potentially changing how it is delivered.
But does that mean liposomal NMN is actually better than normal NMN?
The evidence is more nuanced than many supplement websites suggest.
Editorial disclosure: The Longevity Shop sells NMN supplements, including products referenced in this article. Our comparisons are based on published research, formulation specifications, testing and product characteristics. Where the evidence is limited, we state this clearly.
The Short Answer
Regular NMN currently has considerably more human clinical evidence behind it.
Conventional oral NMN has been investigated in multiple human trials, and studies have repeatedly shown that oral NMN can increase blood NAD-related measurements.
Liposomal NMN has a plausible delivery rationale and early human evidence suggesting that some formulations may produce a stronger NAD+ response than conventional NMN.
However, the direct comparative human evidence remains very limited. One exploratory study comparing liposomal NMN with conventional NMN involved only 15 participants, with five people in each group.
So the most scientifically defensible conclusion at present is:
Liposomal NMN is a promising formulation strategy, but there is not yet enough high-quality human evidence to say that liposomal NMN is universally superior to conventional NMN.
Liposomal NMN vs Regular NMN at a Glance
| Feature | Regular NMN | Liposomal NMN |
|---|---|---|
| Active ingredient | NMN | NMN |
| Delivery format | Powder, capsule or tablet | NMN combined with phospholipids |
| Human NMN research | Relatively extensive | Limited |
| Evidence of increasing NAD+ | Supported by multiple human studies | Preliminary direct evidence |
| Specialised delivery system | No | Yes |
| Proven superior bioavailability | Not applicable | Not conclusively established |
| Manufacturing complexity | Lower | Higher |
| Typical price | Usually lower | Usually higher |
What Is NMN?
NMN stands for nicotinamide mononucleotide.
It is a naturally occurring molecule involved in the body's production of nicotinamide adenine dinucleotide, or NAD+.
NAD+ is a coenzyme involved in many cellular processes, including energy metabolism and enzyme activity.
Interest in NMN has grown because NAD-related metabolism changes with age and because NMN can act as a precursor within pathways used to produce NAD+.
Importantly, this does not mean NMN has been proven to reverse ageing or extend human lifespan.
The most consistently demonstrated human finding is narrower: oral NMN supplementation can increase NAD-related measurements in the blood.
For example, a randomised controlled study using 250mg of conventional NMN per day for 12 weeks reported a significant increase in whole-blood NAD+.
Read the 250mg NMN human study on PubMed
Another randomised trial involving 80 healthy middle-aged adults compared daily doses of 300mg, 600mg and 900mg NMN with placebo. The researchers reported significant increases in blood NAD concentrations in the NMN groups.
Read the 300mg, 600mg and 900mg NMN study on PubMed
What Is Regular NMN?
Regular NMN generally refers to beta-nicotinamide mononucleotide supplied without a specialist lipid-based delivery system.
The NMN may be provided as powder, in a standard capsule or in a tablet.
Once swallowed, the capsule or tablet breaks down and the NMN enters the gastrointestinal environment, where it is exposed to normal digestive and metabolic processes.
This conventional oral format has been used in most published human NMN studies.
Does Normal NMN Work When Taken Orally?
Yes, in the sense that conventional oral NMN has repeatedly demonstrated biological activity in human studies.
This matters because some marketing for advanced delivery systems can create the impression that standard NMN is barely absorbed or ineffective.
The published human evidence does not support such a simple conclusion.
Several studies have reported increases in circulating NAD-related measurements after conventional oral NMN supplementation.
One 12-week study used 250mg per day. Other research has investigated higher doses including 300mg, 600mg and 900mg.
Responses also appear to vary between individuals. This means that the relationship between dose and NAD response may not be identical for everyone.
What Is Liposomal NMN?
Liposomal NMN combines NMN with phospholipids as part of a lipid-based delivery system.
Phospholipids are molecules that contain both water-compatible and fat-compatible regions. Under appropriate manufacturing conditions, they can form microscopic membrane-like structures called liposomes.
Liposomes are already widely studied in pharmaceutical and nutraceutical delivery because they can carry or associate with active compounds.
The rationale is that this type of structure may alter how an ingredient behaves during digestion and absorption.
Why Use Liposomal Technology?
The theoretical advantages of oral liposomal delivery include protecting an active ingredient from parts of the gastrointestinal environment, improving formulation stability and potentially changing how an ingredient interacts with intestinal membranes.
However, oral liposomes face challenges of their own.
The stomach and intestine contain acid, enzymes, bile salts and other substances capable of destabilising lipid structures.
Scientific reviews of oral liposomal delivery therefore describe both the potential advantages and the significant formulation challenges.
Read a scientific review of oral phospholipid vesicle delivery
Read a review of liposomes and oral drug absorption
This means that simply writing "liposomal" on a supplement label does not guarantee better absorption.
Does Liposomal Delivery Improve Absorption in Other Supplements?
There is legitimate human evidence showing that liposomal delivery can improve the bioavailability of some compounds.
For example, human crossover studies comparing conventional and liposomal vitamin C have reported greater systemic exposure from certain liposomal formulations.
Read the human liposomal vitamin C study on PubMed
This demonstrates an important point: oral liposomal delivery technology can work.
It does not prove that every ingredient receives the same benefit.
Results from vitamin C cannot automatically be transferred to NMN.
Has Liposomal NMN Been Compared Directly With Regular NMN?
Yes, but the direct human evidence remains limited.
A small exploratory study published in 2025 compared:
- Placebo
- 350mg per day of conventional NMN
- 350mg per day of liposomal NMN
The trial involved only 15 healthy men over the age of 40, meaning five participants were assigned to each group.
The study lasted four weeks.
The researchers reported that the liposomal NMN group experienced a larger increase in blood NAD+ than the conventional NMN group.
Read the liposomal NMN comparison study
What Did the Liposomal NMN Study Find?
The researchers reported that blood NAD+ in the liposomal group increased from approximately 28.6 micromolar at baseline to approximately 52.5 micromolar after four weeks.
That represents a substantial change in the measured biomarker.
The study also reported a significant difference between the liposomal and conventional NMN groups after four weeks.
That makes the study scientifically interesting, but it does not settle the question of whether liposomal NMN is superior.
Why Doesn't This Prove That Liposomal NMN Is Better?
Only Five People Received Liposomal NMN
This is the most obvious limitation.
When a treatment group contains only five people, an unusually strong or weak response from one participant can materially affect the group average.
The Study Lasted Only Four Weeks
The research provides information about a blood biomarker over a relatively short period.
It does not establish long-term clinical outcomes.
The Study Measured NAD+, Not Longevity
A higher blood NAD+ level does not automatically mean greater longevity, improved cognition, better cardiovascular health or slower biological ageing.
Those outcomes would need to be studied separately.
It Tested One Particular Liposomal Formulation
"Liposomal NMN" is not a single standardised product.
Different products may vary considerably in their phospholipid composition, manufacturing technique, particle size, encapsulation efficiency, stability and NMN concentration.
A result from one formulation therefore cannot prove that every product marketed as liposomal NMN performs in the same way.
The Study Needs Independent Replication
Large, independently conducted trials would provide much stronger evidence than one small exploratory study.
So Is Liposomal NMN Better Absorbed?
The scientifically accurate answer is:
Possibly, but this has not yet been established strongly enough to make a universal claim.
The evidence can be thought of in three stages.
1. The Delivery Mechanism Is Plausible
There are sound scientific reasons for investigating phospholipid-based delivery systems.
2. Liposomal Technology Works for Some Other Nutrients
Human studies demonstrate improved bioavailability for certain liposomal formulations of other compounds.
3. The Direct NMN Evidence Is Preliminary
One small human comparison reported a stronger NAD+ response from liposomal NMN.
That is promising, but it is not equivalent to multiple large, independently replicated pharmacokinetic trials.
Regular NMN Has One Major Advantage: More Human Research
The biggest advantage of conventional NMN is currently the depth of the evidence base.
Most NMN clinical trials have used standard oral NMN.
A systematic review and meta-analysis published in 2024 examined multiple human NMN trials and found that oral supplementation increased NAD-related biomarkers overall.
However, clinically meaningful metabolic outcomes were much less consistent.
Read the NMN systematic review and meta-analysis
Another systematic review examining glucose and lipid metabolism also found that improvements in markers such as fasting glucose, insulin and blood lipids were not consistently demonstrated.
Read the systematic review on NMN and metabolic outcomes
This distinction is important.
NMN can be biologically active without every proposed health benefit being proven.
Does Higher NAD+ Automatically Mean Better Health?
No.
This is one of the most important distinctions when reading NMN research.
A supplement can change a laboratory biomarker without necessarily producing a meaningful improvement in health.
For example, a stronger NAD+ response would be scientifically interesting, but it would not by itself prove improvements in lifespan, cognition, energy, cardiovascular health or physical performance.
Clinical outcome studies are needed for those conclusions.
Liposomal NMN vs Regular NMN: Evidence Comparison
| Question | Regular NMN | Liposomal NMN |
|---|---|---|
| Can it increase NAD-related biomarkers? | Supported by multiple human studies | Supported by preliminary evidence |
| Studied across hundreds of people collectively? | Yes | No |
| Direct comparison available? | One small study | One small study |
| Superior absorption conclusively established? | Not applicable | No |
| Proven to reverse ageing? | No | No |
| Proven to extend human lifespan? | No | No |
| Long-term safety established? | No | No |
Does Liposomal NMN Bypass the Liver?
You may see claims that liposomal supplements completely bypass digestion or bypass the liver.
This is generally too simplistic.
Oral liposomal products still travel through the gastrointestinal tract.
Depending on particle characteristics and formulation, lipid-based delivery systems may alter absorption pathways or affect first-pass exposure.
However, the digestive system is highly effective at processing lipids and membrane structures.
It is therefore not scientifically accurate to assume that every liposomal NMN capsule simply travels intact through the gut and directly into the bloodstream.
Are All Liposomal NMN Supplements the Same?
No.
This is particularly important when comparing products online.
The term "liposomal" describes a formulation approach rather than one universal manufacturing standard.
Two products can both be marketed as liposomal NMN while differing substantially in their composition and quality.
Potential differences include phospholipid concentration, phospholipid source, particle size, encapsulation efficiency, stability, processing method and the amount of NMN actually delivered.
What Should You Look for When Buying Liposomal NMN?
NMN Dose
Check the amount of NMN per recommended daily serving.
Do not confuse the amount per capsule with the full serving if the manufacturer recommends taking two or more capsules.
NMN Purity
A manufacturer should ideally disclose the purity of the NMN ingredient and support it with appropriate testing.
Independent Testing
Testing may cover areas such as NMN identity, potency, purity, heavy metals and microbiological contamination.
Finished-product testing is particularly useful because it assesses what is present in the final product rather than only evaluating the raw ingredient before manufacturing.
Phospholipid Source
A genuine phospholipid-based formulation should disclose the lipid component.
Sunflower lecithin is commonly used as a source of phospholipids.
Formulation Transparency
Ideally, manufacturers of advanced delivery systems should provide more information than simply using the word "liposomal".
Particle-size information, encapsulation efficiency, stability testing and phospholipid composition can all help demonstrate the quality of a liposomal formulation.
Manufacturing Standards
Look for products manufactured under appropriate quality systems and by companies that clearly disclose where and how their supplements are produced.
Packaging
Heat, moisture and light can affect the stability of supplements.
Protective packaging can therefore be an additional quality consideration.
Does Liposomal NMN Mean You Can Take a Lower Dose?
There is currently not enough evidence to establish a universal conversion ratio between regular NMN and liposomal NMN.
Claims such as:
"250mg of liposomal NMN is equivalent to 500mg of standard NMN"
would require product-specific pharmacokinetic evidence.
At present, there is no generally accepted clinical conversion formula.
What Doses of Regular NMN Have Been Studied?
Human trials have investigated a relatively wide range of doses.
Examples include 250mg, 300mg, 600mg, 900mg and higher amounts in short-term safety studies.
A four-week safety study investigated 1,250mg of beta-NMN per day in healthy adults without identifying major safety abnormalities during the short study period.
View the 1,250mg NMN safety study on PubMed
This does not mean 1,250mg is an optimal dose.
Is 500mg of NMN a Reasonable Dose?
There is currently no officially established optimal daily NMN dose.
However, 500mg falls between several amounts that have already been investigated in human research.
It therefore represents a practical middle-ground formulation level, although there is no evidence demonstrating that exactly 500mg is universally optimal.
Is NMN Safe?
Published short-term human studies have generally reported good tolerability.
However, most studies have been relatively short.
The existing evidence should therefore not be interpreted as proving the safety of taking NMN continuously for decades.
Longer and larger studies are still required.
Is Liposomal NMN Safer Than Regular NMN?
There is currently no convincing evidence showing that liposomal NMN is safer than conventional NMN.
Likewise, there is not enough evidence to conclude that it is less safe.
The comparative evidence is simply too limited.
Liposomal NMN or Regular NMN: Which Should You Choose?
Neither format is automatically the right choice for everyone.
If you prioritise the formulation with the largest current human evidence base, conventional NMN has the advantage.
If you are particularly interested in advanced delivery technology and phospholipid-based formulations, liposomal NMN may be appealing, provided you understand that the direct comparative human evidence remains preliminary.
The quality of the actual supplement may ultimately matter more than whether the front of the bottle says "liposomal".
An Example of Liposomal NMN: Charava Liposomal NMN 500mg
Charava Liposomal NMN 500mg is one example of a phospholipid-based NMN formulation available to UK consumers.
The recommended two-capsule serving provides 500mg of NMN, with 250mg per capsule.
The formulation combines NMN with sunflower-derived phospholipids and uses a vegetable capsule.
Charava states that its NMN has 99.8% purity and is third-party tested.
| Specification | Charava Liposomal NMN 500mg |
|---|---|
| NMN per capsule | 250mg |
| Recommended serving | 2 capsules |
| NMN per serving | 500mg |
| Stated NMN purity | 99.8% |
| Phospholipid source | Sunflower-derived phospholipids |
| Capsule | Hypromellose vegetable capsule |
| Vegan | Yes |
| Testing | Third-party tested |
| Manufacturing | United Kingdom |
| Packaging | Amber glass bottle |
These are product specifications. They should not be interpreted as evidence that this particular formulation produces superior clinical outcomes to every conventional NMN supplement.
View Charava Liposomal NMN 500mg
What Makes a Good NMN Supplement?
Whether you choose conventional NMN or liposomal NMN, we believe the most important factors are a clearly disclosed dose, high-purity beta-NMN, independent testing, transparent ingredients, appropriate manufacturing standards, suitable packaging and realistic claims based on human evidence.
The final point is particularly important.
A company willing to explain where the evidence remains uncertain is generally more useful to consumers than one promising that NMN will "reverse ageing".
Our View: Is Liposomal NMN Worth It?
Liposomal NMN is scientifically interesting.
The delivery concept is credible.
Research involving other nutrients shows that phospholipid-based systems can improve bioavailability in some circumstances.
And the first small direct comparison of liposomal and regular NMN provides an encouraging signal that one liposomal formulation may produce a stronger blood NAD+ response.
But the evidence is not yet strong enough to say:
"Liposomal NMN is proven to be better than normal NMN."
Our assessment is therefore:
Regular NMN currently wins on depth of human clinical evidence.
Liposomal NMN offers a more sophisticated delivery concept, with encouraging but still limited direct human comparative evidence.
For buyers considering liposomal NMN, the smartest approach is to evaluate the entire product rather than simply looking for the word "liposomal".
Consider the actual NMN dose, purity, independent testing, phospholipid formulation, manufacturing quality and transparency.
If you are comparing specific NMN products rather than delivery formats, read our guide to the best NMN supplements in the UK.
Frequently Asked Questions
What is the difference between liposomal NMN and normal NMN?
Normal NMN contains NMN without a specialist lipid carrier. Liposomal NMN combines NMN with phospholipids as part of a lipid-based delivery system intended to alter or potentially improve delivery through the gastrointestinal environment.
Is liposomal NMN better absorbed?
Possibly. One small human trial reported a larger increase in blood NAD+ with a liposomal NMN formulation than with conventional NMN. However, only five participants received each treatment, so larger independent studies are needed.
Does normal NMN absorb?
Conventional oral NMN clearly has biological activity. Multiple human studies have reported significant increases in blood NAD-related biomarkers following supplementation.
Is liposomal NMN proven to work better?
No. The direct comparative evidence is currently too limited to conclude that liposomal NMN is universally superior to conventional NMN.
Does liposomal NMN bypass digestion?
No. Oral liposomal formulations still pass through the gastrointestinal tract, where phospholipid structures are exposed to acid, enzymes, bile salts and other digestive processes.
Can I take less liposomal NMN because it is better absorbed?
There is currently no established universal dose-conversion ratio between conventional and liposomal NMN. Product-specific evidence would be required to support such a claim.
Is liposomal NMN more expensive?
It often is because lipid-based formulations can involve additional ingredients and more complex manufacturing.
How much liposomal NMN should I take?
There is no clinically established universal dose specifically for liposomal NMN. Follow the recommended serving for the particular product and seek professional medical advice where appropriate.
Does NMN reverse ageing?
No human clinical evidence has demonstrated that NMN reverses ageing or extends human lifespan.
Does NMN increase NAD+?
Multiple human studies using conventional oral NMN have reported increases in blood NAD-related measurements.
Key Takeaway
The simplest way to understand the difference is:
Regular NMN has the stronger clinical evidence base. Liposomal NMN is a more advanced delivery concept with promising but still limited direct human comparative evidence.
That may change as larger clinical trials become available.
For now, consumers should focus less on marketing terminology and more on dose, purity, independent testing, formulation quality and transparent evidence.
Research and References
1. Oral NMN, 250mg daily for 12 weeks
Human randomised controlled study examining safety and changes in blood NAD+.
View on PubMed
2. NMN dose-ranging study: 300mg, 600mg and 900mg
Randomised clinical study in healthy middle-aged adults.
View on PubMed
3. Liposomal NMN vs conventional NMN
Small exploratory human comparison of 350mg conventional NMN, 350mg liposomal NMN and placebo.
Read the paper
4. Systematic review and meta-analysis of oral NMN
Review of human NMN trials and NAD-related and metabolic outcomes.
View on PubMed
5. NMN and glucose and lipid metabolism
Systematic review and meta-analysis of randomised controlled trials.
View on PubMed
6. Liposomal vitamin C human absorption study
Human research illustrating the potential bioavailability advantages of certain oral liposomal delivery systems.
View on PubMed
7. Oral phospholipid vesicle delivery review
Scientific review of the opportunities and challenges involved in oral liposomal delivery.
View on PubMed
8. Liposomes and oral drug absorption
Review examining the mechanisms and limitations of liposomes as oral delivery systems.
View on PubMed
9. High-dose NMN safety study
Short-term human study investigating 1,250mg of beta-NMN per day.
View on PubMed
10. Charava Liposomal NMN 500mg
Product formulation and specification information.
View the product
Important: This article is provided for general educational purposes and does not constitute medical advice. Research into NMN and liposomal NMN is ongoing, and findings may change as new evidence becomes available. Food supplements should not be used as a substitute for a varied, balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or receiving treatment for a medical condition, consult an appropriate healthcare professional before using supplements. We may earn a commission for affiliate sales.